TrialOrphanet journal of rare diseases2020

Inhaled granulocyte-macrophage colony stimulating factor for mild-to-moderate autoimmune pulmonary alveolar proteinosis - a six month phase II randomized study with 24 months of follow-up.

Xinlun Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.